Moreover, the low level of CDC42 K153 acetylation in CRC predicted a poor outcome for the patients, thereby suggesting that CDC42 K153 acetylation may have a prognostic value for patients with CRC. The gene discussed is CDC42; the disease is colorectal carcinoma.